Study | Alzheimer’s disease-related pathologies | α-Syn | TDP-43 | HS | Vascular pathologies | Mixed pathology | ||
---|---|---|---|---|---|---|---|---|
 | Braak III to VI | CERAD | NIA |  |  |  |  |  |
 |  | 59% (195) | 15% (195) |  | 13% (100) | 46%a (195) | 23% (195) | |
 |  | 61% (386) | 21% (386) | 46% (130) | 13% (100) | 49%a (386) | 28% (386) | |
52% (456) | 46% (456) | Â | 39% (29% amygdala) (208) | Â | Â | 70%b (456) | Â | |
CC75C [40] | 39%c (213) | 28% (213) | Â | 15% (213) | Â | Â | 56%d (213) | Â |
70% (304) | 66% (180) | 41%e (180) | 36% (304) | Â | 5% (132) | 55%a (132) | 40% (132) | |
 |  | 62% (205) | 29% (205) |  |  | 31% (29) | 10%g (29) | |
HAAS [48] | Â | Â | 19%h (363) | 10%f (363) | Â | 9%f (363) | 28%d (363) | 39.5% (363) |
ACT [49] | 62% (438) | 47% (438) | Â | 14% (438) | Â | Â | 35%d (438) | Â |
 |  | 56%i (209) | 6%f (34) |  |  | 44%a (179) |  | |
OBAS [53] | 62% (71) | 44% (71) | Â | 20% (71) | Â | 7% (71) | 46%d (71) | Â |
90+ Study [55] | Â | Â | 67% (108) | 6%j (108) | 31% (108) | 29%f (66) | Â | 19%k (108) |
VITA [5] | 38% (233) | 35% (233) | Â | 25% (17.2% amygdala) (233) | 13% (233) | 3% (233) | 49%l (233) | 74% (233) |